… One systematic review of seven randomized trials found inconclusive evidence … study,
we gave quinine plus clindamycin treatment twice daily for three days based on a meta-analysis …

… with cure rates … treated with quinine plus clindamycin in our study were still parasitaemic
on day 3. However, they confirm that the mean parasite clearance with quinine plus clindamycin …

… and clindamycin is recommended as a second-line medicine for uncomplicated falciparum
malaria by WHO in 2010. This combination could remedy ACT shortfall in some regions. Both …

… One systematic review of seven … this study, we gave quinine plus clindamycin treatment
twice daily for three days based on a meta-analysis of quinine plus clindamycin vs quinine alone …

… (ACTs) for the treatment of uncomplicated falciparum malaria in the second and third … We
conducted a meta-analysis to compare efficacy, safety and tolerability of ACTs versus quinine …

… as first line treatment, then ASAQ, AL and oral Quinine plus clindamycin (QnC) when used
as rescue treatment. Furthermore, ASAQ safety for repeated recurrent uncomplicated malaria …

… was less preferable than ACTs because of higher treatment failure, unless combined with
clindamycin, higher occurrence of acute adverse events (ie, lower tolerability), and higher risk …

… In comparative trials, clindamycin combined with quinine improved the cure rate of South
America (26-28). Children with severe Plasmodium falciparum malaria were enrolled in the …

… before this study Artemisinin-based combination therapies (ACTs) are recommended for
first-line treatment of uncomplicated Plasmodium falciparum malaria. If recurrent malaria occurs …

… study is to provide a current systematic review and meta-analysis on ACT at Mali study sites,
where falciparum … sites showed that ACT yielded lower failure rates (relative to oral quinine) …